Skip to main content
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: J Magn Reson Imaging. 2018 Mar 31;48(5):1326–1335. doi: 10.1002/jmri.26025

Figure 1.

Figure 1

Performance of clinically significant cancer detection in PI-RADSv2 (red) vs in-house (blue) systems. ROC curves for (A) all cancer detection with PI-RADSv2 AUC 76% and in-house AUC 78% (p=0.20) and (B) for clinically significant cancer, each with AUC = 79%.